UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009141
Receipt number R000010714
Scientific Title Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.
Date of disclosure of the study information 2013/01/01
Last modified on 2012/10/18 16:46:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Acronym

Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Scientific Title

Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Scientific Title:Acronym

Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Region

Japan


Condition

Condition

Being prepared.

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will investigate the usefulness of femoral nerve block and tibial nerve block in patients undergoing bilateral knee replacement.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Femoral nerve block with different concentrations will cause the same analgesic effect.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Femoral nerve blockade with 0.25% levobupivacaine.

Interventions/Control_2

Femoral nerve blockade with 0.125% levobupivacaine.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

ASA physical status classification I or II.

Key exclusion criteria

Central or peripheral nerve dysfunction.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kashiwai Akihiro

Organization

Nihon University Itabashi Hospital

Division name

Department of Anesthesiology

Zip code


Address

30-1, Oyaguchi-Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Nihon University Itabashi Hospital

Division name

Department of Anesthesiology

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Ryoji Iida

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 10 Month 18 Day

Last modified on

2012 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010714


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name